Durect (DRRX) Price & Analysis

Compare

1,438 Followers

DRRX Stock Chart & Stats

Day’s Range― - ―

52-Week Range$0.48 - $2.64

Previous CloseN/A

Volume18.67K

Average Volume (3M)728.20K

Market Cap

$59.31M

Enterprise Value$14.97M

Total Cash (Recent Filing)$6.50M

Total Debt (Recent Filing)$1.75M

Price to Earnings (P/E)―

Beta-1.58

Next Earnings

Oct 29, 2025

EPS Estimate

-0.18

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.07

Shares Outstanding31,054,000

10 Day Avg. Volume866,862

30 Day Avg. Volume728,204

Financial Highlights & Ratios

PEG Ratio0.04

Price to Book (P/B)2.54

Price to Sales (P/S)11.43

P/FCF Ratio-1.22

Enterprise Value/Market Cap0.25

Enterprise Value/Revenue4.75

Enterprise Value/Gross Profit5.90

Enterprise Value/Ebitda-1.01

Forecast

1Y Price Target

$2.50

Price Target Upside30.89% Upside

Rating ConsensusHold

Number of Analyst Covering1

Bulls Say, Bears Say

Bulls Say

Clinical Trial Success90-day mortality reductions were statistically significant in U.S. patients treated with larsucosterol at either dose in the Phase 2b AHFIRM trial.

Regulatory ApprovalThe FDA has granted larsucosterol Fast Track Designation and Breakthrough Therapy Designation for the treatment of alcohol-associated hepatitis.

Bears Say

Financial RiskDURECT is viewed as a significant 'going concern' risk with its current cash runway that extends into 1Q25.

Funding ChallengesThere remains significant uncertainty regarding the available options to finance the Phase 3 study.

Durect News

Unusually active option classes on open September 10th

Unusual total active option classes on open include: Durect (DRRX), Asset Entities Inc (ASST), Bitfarms (BITF), Compass Inc...

8d ago

LDI

Bausch Health announces extension of Durect tender offer

Bausch Health Companies (BHC) and DURECT Corporation (DRRX) announced that BHC Lyon Merger Sub, a wholly owned subsidiary...

23d ago

BHC

DRRX

Durect Merges with Bausch Health, Delists from Nasdaq

Durect ( ($DRRX) ) has issued an announcement. On September 11, 2025, DURECT Corporation completed a merger with...

7d ago

DRRX

DURECT Corporation Reports Q2 2025 Results Amid Acquisition

DURECT Corporation ( ($DRRX) ) has released its Q2 earnings. Here is a breakdown of the information DURECT...

1M ago

DRRX

Durect, Bausch Health merger expected to close in Q3

16:37 EDT Durect (DRRX), Bausch Health (BHC) merger expected to close in Q3 Published first on TheFly –...

1M ago

BHC

DRRX

Durect reports Q2 cont ops EPS (7c) vs. (13c) last year

Reports Q2 revenue $447,000 vs. $646,000 last year. As of June 30, 2025, cash, cash equivalents and investments...

1M ago

DRRX

Durect, Bausch Health merger expected to close in Q3

16:34 EDT Durect (DRRX), Bausch Health merger expected to close in Q3 Published first on TheFly – the...

1M ago

DRRX

Durect options imply 6.9% move in share price post-earnings

Pre-earnings options volume in Durect (DRRX) is normal with puts leading calls 11:1. Implied volatility suggests the market...

1M ago

DRRX

Is DRRX a Buy, Before Earnings?

DURECT Corporation (DRRX) is scheduled to report 2nd quarter earnings on 08/12/2025. Regarding Q2 estimates, Wall Street analysts...

1M ago

DRRX

Durect Extends Tender Offer Deadline in Merger

Durect ( ($DRRX) ) has shared an announcement. On July 28, 2025, Durect Corporation entered into a Merger...

1M ago

DRRX

Why Is Durect Stock (DRRX) Up 270% Today?

Durect stock was up on Tuesday after the company announced an acquisition agreement with Bausch Health. ...

2M ago

BCH

DRRX

Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!

Earnings season is in full swing and TipRanks is home to all of the hottest coverage. ...

2M ago

Durect downgraded to Market Perform from Outperform at Northland

Northland downgraded Durect (DRRX) to Market Perform from Outperform with a $2.50 price target after Bausch Health (BHC)...

2M ago

DRRX

Durect Merges with Bausch Health for $1.75/Share

Durect ( ($DRRX) ) just unveiled an update. On July 28, 2025, DURECT Corporation entered into a merger...

2M ago

DRRX

DRRX FAQ

What was DURECT Corporation’s price range in the past 12 months?

DURECT Corporation lowest stock price was $0.48 and its highest was $2.64 in the past 12 months.

What is DURECT Corporation’s market cap?

DURECT Corporation’s market cap is $59.31M.

When is DURECT Corporation’s upcoming earnings report date?

DURECT Corporation’s upcoming earnings report date is Oct 29, 2025 which is in 41 days.

How were DURECT Corporation’s earnings last quarter?

DURECT Corporation released its earnings results on Aug 12, 2025. The company reported -$0.07 earnings per share for the quarter, beating the consensus estimate of -$0.13 by $0.06.

Is DURECT Corporation overvalued?

According to Wall Street analysts DURECT Corporation’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does DURECT Corporation pay dividends?

DURECT Corporation does not currently pay dividends.

What is DURECT Corporation’s EPS estimate?

DURECT Corporation’s EPS estimate is -0.18.

How many shares outstanding does DURECT Corporation have?

DURECT Corporation has 31,054,000 shares outstanding.

What happened to DURECT Corporation’s price movement after its last earnings report?

DURECT Corporation reported an EPS of -$0.07 in its last earnings report, beating expectations of -$0.13. Following the earnings report the stock price went down -0.524%.

Which hedge fund is a major shareholder of DURECT Corporation?

Among the largest hedge funds holding DURECT Corporation’s share is Moore Capital Management LP. It holds DURECT Corporation’s shares valued at 0.

Durect Stock Smart Score

Neutral

Fundamentals

Return on Equity

-291.74%

Trailing 12-Months

Asset Growth

-58.19%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

DURECT Corporation

Durect Corporation (DRRX) is a biopharmaceutical company focused on developing innovative therapeutics for the treatment of chronic pain and other serious diseases. The company specializes in drug delivery systems and has developed a portfolio of proprietary technologies, including its DUR-928 product candidate, aimed at treating a variety of conditions. Durect operates primarily in the pharmaceutical sector, leveraging its expertise in formulation and delivery systems to create effective and safe medicinal products.

Durect (DRRX) Earnings & Revenues

Historic Earnings Reports

DRRX Stock 12 Month Forecast

Average Price Target

$2.50

▲(30.89% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","1":"$1","2":"$2","3":"$3","-1":"-$1"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$2.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$2.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$2.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,0,1,2,3],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Dec<br/>2024","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.64,0.7830769230769231,0.9261538461538461,1.0692307692307692,1.2123076923076923,1.3553846153846154,1.4984615384615383,1.6415384615384614,1.7846153846153845,1.9276923076923076,2.0707692307692307,2.213846153846154,2.356923076923077,{"y":2.5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.64,0.7830769230769231,0.9261538461538461,1.0692307692307692,1.2123076923076923,1.3553846153846154,1.4984615384615383,1.6415384615384614,1.7846153846153845,1.9276923076923076,2.0707692307692307,2.213846153846154,2.356923076923077,{"y":2.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.64,0.7830769230769231,0.9261538461538461,1.0692307692307692,1.2123076923076923,1.3553846153846154,1.4984615384615383,1.6415384615384614,1.7846153846153845,1.9276923076923076,2.0707692307692307,2.213846153846154,2.356923076923077,{"y":2.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.98,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.97,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.71,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.53,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.48,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.34,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.92,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.75,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.8,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.8,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.58,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.53,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.64,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >